Skip to main content
logo
XORTX Therapeutics logo
XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
1.420
-0.140 (-8.97%)
At close: Oct 15, 2026, 4:00 PM EDT
1.370
-0.050 (-3.52%)
After-hours: Oct 15, 2026, 7:53 PM EDT

XORTX Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Market Capitalization
34451227
Market Cap Growth
-43.43%-0.50%-14.83%-60.29%-56.34%182.78%
Enterprise Value
232-0323
Last Close Price
1.422.815.6511.5536.3692.25

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
PB Ratio
0.451.881.181.001.662.02
P/TBV Ratio
0.872.061.251.031.712.05

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Debt / Equity Ratio
-0.020.010.000.01-
Net Debt / Equity Ratio
-0.18-0.40-0.73-0.74-1.48-1.13
Net Debt / EBITDA Ratio
0.460.330.940.711.126.48
Net Debt / FCF Ratio
0.200.300.660.521.263.10
Quick Ratio
1.591.583.294.256.9626.97
Current Ratio
3.592.113.534.937.2128.78
Return on Equity (ROE)
-99.24%-98.00%-83.06%-37.08%-76.43%-22.25%
Return on Assets (ROA)
-29.85%-46.84%-34.21%-34.72%-38.82%-15.04%
Return on Capital Employed (ROCE)
-38.70%-121.80%-78.40%-106.80%-85.10%-13.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Earnings Yield
-144.95%-67.89%-84.25%-46.74%-66.39%-5.93%
FCF Yield
-197.73%-70.76%-93.54%-142.67%-70.40%-18.03%
Buyback Yield / Dilution
-93.11%-64.48%-45.25%-33.91%-35.25%-47.77%
SEC Filings: 10-K · 10-Q